Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Anixa Biosciences Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 42 | 41 | −1 |
| Shares | 3.44M | 3.30M | −133.4K (−3.9%) |
| Value | $10.2M | $9.05M | −$1.16M (−11.3%) |
New holders (6)
Institutions that held Anixa Biosciences Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 16,073 | $44.0K | 0.00% |
| Keybank National Association | 15,510 | $42.0K | 0.00% |
| Captrust Financial Advisors | 5,000 | $14.0K | 0.00% |
| Strategic Asset Management, LLC | 3,700 | $10.0K | 0.01% |
| Tucker Asset Management LLC | 600 | $1.64K | 0.00% |
| Larson Financial Group LLC | 500 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Anixa Biosciences Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Two Sigma Investments, LP | 36,350 | $108.0K |
| Citadel Advisors LLC | 33,935 | $101.0K |
| Virtu Financial LLC | 28,201 | $84.0K |
| Jump Financial, LLC | 26,000 | $77.0K |
| Susquehanna International Group, LLP | 19,300 | $57.0K |
| ExodusPoint Capital Management, LP | 10,029 | $30.0K |
| Cedar Brook Financial Partners, LLC | 10,000 | $30.0K |